Putthiporn Charoenphun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Putthiporn Charoenphun has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Krisanat Chuamsaamarkkee
Faculty of Medicine Ramathibodi Hospital Department of Diagnostic and Therapeutic Radiology Division of Nuclear Medicine Mahidol University Thailand Bangkok
5 shared publications - Wichana Chamroonrat
Division of Nuclear Medicine, Department of Diagnostic and Therapeutic Radiology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand
2 shared publications - Abdelhamid Elaissari
Université Lyon-1
1 shared publication - Benjapa Khiewvan
Faculty of Medicine Siriraj Hospital Department of Radiology Division of Nuclear Medicine Mahidol University Thailand Bangkok
1 shared publication - Chayanit Jumpee
Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand
1 shared publication Duangporn Polpanich
1 shared publication
Latest Publications
- Open Access
- 3 February 2026
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 35 (1) , 78-83
First Southeast Asian Experience of Terbium-161 PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Quantitative Imaging and Dosimetric Approach
First Southeast Asian Experience of Terbium-161 PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Quantitative Imaging and Dosimetric Approach - Molecular Imaging and Radionuclide Therapy
- 3 February 2026
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 35 (1) , 78-83
Open AccessFirst Southeast Asian Experience of Terbium-161 PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Quantitative Imaging and Dosimetric Approach
First Southeast Asian Experience of Terbium-161 PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Quantitative Imaging and Dosimetric Approach - Molecular Imaging and Radionuclide Therapy
- 4 January 2026
- Published by Chiang Mai University in Journal of Associated Medical Sciences
- Vol. 59 (1) , 9-17
Single time-point kidney dosimetry in 177Lu-PSMA therapy: A comparison between AI-based and manual segmentation approaches
Background: Single time-point (STP) dosimetry has become a practical and efficient approach for personalised radioligand therapy (RLT), with 48-hours post-injection identified as optimal for kidney dose estimation in ¹⁷⁷Lu-PSMA therapy for prostate cancer. However, segmentation accuracy remains a critical factor affecting dosimetry reliability. AI-based segmentation has recently been integrated into commercial software to improve efficiency and reduce variability. Objectives: This study aims to quantify kidney absorbed doses in patients receiving ¹⁷⁷Lu-PSMA therapy using STP dosimetry and to compare the accuracy and consistency of AI-based segmentation versus manual segmentation techniques. Materials and methods: Eight treatment cycles from 5 patients of ¹⁷⁷Lu-PSMA were retrospectively analysed. In this work, whole-body SPECT/CT imaging was performed approximately 48 hours post-injection. Then, kidney dosimetry was calculated using voxel-based STP (Hänscheid method) within MIM SurePlan™ MRT software. Kidney volumes of interest (VOIs) were segmented using three approaches: 1) AI-based automatic segmentation, 2) AI-based with manual refinement, and 3) fully manual segmentation. Mean absorbed doses and VOI volumes were compared across methods. Statistical analyses included ANOVA, Dice Similarity Coefficient (DSC), and Jaccard Similarity Coefficient (JSC). Results: No significant differences in mean kidney absorbed doses were found across segmentation methods (p=0.964), while kidney VOI volumes showed significant variation (p<0.05). AI-based segmentation achieved high concordance with manual delineation (DSC: 0.898±0.019; JSC: 0.816±0.031). Conclusion: AI-based segmentation provides comparable absorbed dose results to manual segmentation, with reduced time and inter-observer variability.
- 4 January 2026
- Published by Chiang Mai University in Journal of Associated Medical Sciences
- Vol. 59 (1) , 9-17
Single time-point kidney dosimetry in 177Lu-PSMA therapy: A comparison between AI-based and manual segmentation approaches
Background: Single time-point (STP) dosimetry has become a practical and efficient approach for personalised radioligand therapy (RLT), with 48-hours post-injection identified as optimal for kidney dose estimation in ¹⁷⁷Lu-PSMA therapy for prostate cancer. However, segmentation accuracy remains a critical factor affecting dosimetry reliability. AI-based segmentation has recently been integrated into commercial software to improve efficiency and reduce variability. Objectives: This study aims to quantify kidney absorbed doses in patients receiving ¹⁷⁷Lu-PSMA therapy using STP dosimetry and to compare the accuracy and consistency of AI-based segmentation versus manual segmentation techniques. Materials and methods: Eight treatment cycles from 5 patients of ¹⁷⁷Lu-PSMA were retrospectively analysed. In this work, whole-body SPECT/CT imaging was performed approximately 48 hours post-injection. Then, kidney dosimetry was calculated using voxel-based STP (Hänscheid method) within MIM SurePlan™ MRT software. Kidney volumes of interest (VOIs) were segmented using three approaches: 1) AI-based automatic segmentation, 2) AI-based with manual refinement, and 3) fully manual segmentation. Mean absorbed doses and VOI volumes were compared across methods. Statistical analyses included ANOVA, Dice Similarity Coefficient (DSC), and Jaccard Similarity Coefficient (JSC). Results: No significant differences in mean kidney absorbed doses were found across segmentation methods (p=0.964), while kidney VOI volumes showed significant variation (p<0.05). AI-based segmentation achieved high concordance with manual delineation (DSC: 0.898±0.019; JSC: 0.816±0.031). Conclusion: AI-based segmentation provides comparable absorbed dose results to manual segmentation, with reduced time and inter-observer variability.
- Open Access
- 1 January 2025
- Published by National Library of Serbia in Nuclear Technology and Radiation Protection
- Vol. 40 (4) , 303-311
Monte Carlo simulation of eye lens dose and shielding effectiveness for radiation workers in nuclear medicine
The aim of this work was to estimate the eye lens dose equivalent at a depth of 3 mm and to evaluate the effectiveness of shielding for radiation workers in nuclear medicine using Monte Carlo simulation with the Monte Carlo N-Particle transport code, version 5. Published air kerma rate constants were used to validate the simulation code for commonly used radionuclides in nuclear medicine, including $ ^{18}\mathrm{F} $, $ ^{99m}\mathrm{Tc} $, and $ ^{131}\mathrm{I} $. Eye lens dose rates with commercially available syringe shields and vial shields were simulated using the Monte Carlo N-Particle code with the Posture, Individual, and Medical Application Laboratory phantom. Shielded and unshielded eye lens dose rates based on commercially available source data were simulated for common radionuclides at various distances. The maximum number of procedures was also estimated based on the eye lens dose limit recommended by the International Commission on Radiological Protection publication 118. The simulated dose rates may be used to evaluate radiation safety considerations for workers in nuclear medicine. Appropriate shielding and eye lens monitoring are particularly recommended for positron-emitting $ ^{18}\mathrm{F} $ and high-activity $ ^{131}\mathrm{I} $ procedures.- 1 January 2025
- Published by National Library of Serbia in Nuclear Technology and Radiation Protection
- Vol. 40 (4) , 303-311
Open AccessMonte Carlo simulation of eye lens dose and shielding effectiveness for radiation workers in nuclear medicine
The aim of this work was to estimate the eye lens dose equivalent at a depth of 3 mm and to evaluate the effectiveness of shielding for radiation workers in nuclear medicine using Monte Carlo simulation with the Monte Carlo N-Particle transport code, version 5. Published air kerma rate constants were used to validate the simulation code for commonly used radionuclides in nuclear medicine, including $ ^{18}\mathrm{F} $, $ ^{99m}\mathrm{Tc} $, and $ ^{131}\mathrm{I} $. Eye lens dose rates with commercially available syringe shields and vial shields were simulated using the Monte Carlo N-Particle code with the Posture, Individual, and Medical Application Laboratory phantom. Shielded and unshielded eye lens dose rates based on commercially available source data were simulated for common radionuclides at various distances. The maximum number of procedures was also estimated based on the eye lens dose limit recommended by the International Commission on Radiological Protection publication 118. The simulated dose rates may be used to evaluate radiation safety considerations for workers in nuclear medicine. Appropriate shielding and eye lens monitoring are particularly recommended for positron-emitting $ ^{18}\mathrm{F} $ and high-activity $ ^{131}\mathrm{I} $ procedures. - 13 June 2022
- Published by Elsevier in Radiation Physics and Chemistry
- Vol. 199
Flexible gamma ray shielding based on natural Rubber/BaSO4 nanocomposites
- 13 June 2022
- Published by Elsevier in Radiation Physics and Chemistry
- Vol. 199
Flexible gamma ray shielding based on natural Rubber/BaSO4 nanocomposites
- Open Access
- 20 July 2021
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 11 (41) , 25199-25206
A model of modified meta-iodobenzylguanidine conjugated gold nanoparticles for neuroblastoma treatment
127I-modified mIBG was successfully synthesized and grafted covalently to the surface of carboxylated PEG-GNPs. The particles were not toxic to the normal fibroblast cells while specifically internalized into neuroblastoma cells line via NET.
- 20 July 2021
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 11 (41) , 25199-25206
Open AccessA model of modified meta-iodobenzylguanidine conjugated gold nanoparticles for neuroblastoma treatment
127I-modified mIBG was successfully synthesized and grafted covalently to the surface of carboxylated PEG-GNPs. The particles were not toxic to the normal fibroblast cells while specifically internalized into neuroblastoma cells line via NET.
- Open Access
- 1 October 2020
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 29 (3) , 124-131
Red Marrow Absorbed Dose Calculation in Thyroid Cancer Patient Using a Simplified Excel Spreadsheet
Absorbed dose to red marrow (Drm) can be calculated using blood dosimetry. However, this method is laborious and invasive. Therefore, image-based dosimetry is the method of choice. Nonetheless, the commercial software is expensive. The goal of this work was to develop a simplified excel spreadsheet for image-based radioiodine red marrow dosimetry. The serial whole-body images (acquired at 2nd, 6th, 24th, 48th, and 72th hours) of 29 patients from the routine pretherapeutic dosimetry protocol were retrospectively reanalyzed. The commercial OLINDA/EXM image-based dosimetry software was used to calculate the whole-body time-integrated activity coefficient (TIACWB) and Drm [in terms of absorbed dose coefficient (drm)]. For the simplified excel spreadsheet, the whole-body count was obtained from the vendor-supplied software. Then, the TIACWB was computed by a fitting time-activity curve using an Excel function. S factor was taken from other publications and scaled according to the patient-specific mass. A comparison of the TIACWB and drm from both methods was done using a non-inferiority test using a paired t-test or the Wilcoxon signed-rank test. The TIACWB showed no significant difference between both methods (p=0.243). The calculated Drm from a simplified Excel spreadsheet was assumed to be statistically non-inferior to the commercial OLINDA/EXM image-based dosimetry software with the non-inferiority margin of 0.02 (p<0.05). The dose assessment from a simplified Excel spreadsheet is feasible and relatively low cost compared to the commercial OLINDA/EXM image-based dosimetry software.
- 1 October 2020
- Published by Galenos Yayinevi in Molecular Imaging and Radionuclide Therapy
- Vol. 29 (3) , 124-131
Open AccessRed Marrow Absorbed Dose Calculation in Thyroid Cancer Patient Using a Simplified Excel Spreadsheet
Absorbed dose to red marrow (Drm) can be calculated using blood dosimetry. However, this method is laborious and invasive. Therefore, image-based dosimetry is the method of choice. Nonetheless, the commercial software is expensive. The goal of this work was to develop a simplified excel spreadsheet for image-based radioiodine red marrow dosimetry. The serial whole-body images (acquired at 2nd, 6th, 24th, 48th, and 72th hours) of 29 patients from the routine pretherapeutic dosimetry protocol were retrospectively reanalyzed. The commercial OLINDA/EXM image-based dosimetry software was used to calculate the whole-body time-integrated activity coefficient (TIACWB) and Drm [in terms of absorbed dose coefficient (drm)]. For the simplified excel spreadsheet, the whole-body count was obtained from the vendor-supplied software. Then, the TIACWB was computed by a fitting time-activity curve using an Excel function. S factor was taken from other publications and scaled according to the patient-specific mass. A comparison of the TIACWB and drm from both methods was done using a non-inferiority test using a paired t-test or the Wilcoxon signed-rank test. The TIACWB showed no significant difference between both methods (p=0.243). The calculated Drm from a simplified Excel spreadsheet was assumed to be statistically non-inferior to the commercial OLINDA/EXM image-based dosimetry software with the non-inferiority margin of 0.02 (p<0.05). The dose assessment from a simplified Excel spreadsheet is feasible and relatively low cost compared to the commercial OLINDA/EXM image-based dosimetry software.